AllPeptides.eu - Advanced Peptide Research
    Back to matrix
    Neuro

    Semax

    None of the 30 tracked EU+ jurisdictions lists Semax as authorised. This page summarises approval status, brands, shortages and recent regulatory changes by country.

    Protocol detail references

    5mg10mg

    Related regulatory compounds

    PT-141 (Bremelanotide)Selank

    Country-by-country approval and availability

    30 EU+ jurisdictions covered.

    🇩🇪
    Germany

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    France

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇮🇹
    Italy

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇪🇸
    Spain

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇳🇱
    Netherlands

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇬🇷
    Greece

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇸🇪
    Sweden

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇩🇰
    Denmark

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇫🇮
    Finland

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇦🇹
    Austria

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇧🇪
    Belgium

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇱🇺
    Luxembourg

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇵🇹
    Portugal

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇮🇪
    Ireland

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇵🇱
    Poland

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇨🇿
    Czech Republic

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇸🇰
    Slovakia

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇭🇺
    Hungary

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇸🇮
    Slovenia

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇭🇷
    Croatia

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇪🇪
    Estonia

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇱🇻
    Latvia

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇱🇹
    Lithuania

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇷🇴
    Romania

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇧🇬
    Bulgaria

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇨🇾
    Cyprus

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇲🇹
    Malta

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇬🇧
    United Kingdom

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇨🇭
    Switzerland

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only
    🇳🇴
    Norway

    No EMA/MHRA/Swissmedic approval. Research use only.

    Research only

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu

    Join on TelegramJoin on WhatsApp